Mergers & Acquisitions ·
FOXO Technologies Inc.'s subsidiary, Vector BioSource, Inc., entered into a definitive agreement to acquire four…
FOXODFoxo Technologies Inc.
FOXO Technologies Inc.'s subsidiary, Vector BioSource, Inc., entered into a definitive agreement to acquire four U.S.-based blood collection centers from Grifols Bio Supplies, Inc. The transaction involves an upfront cash payment and potential future earnout payments contingent on EBITDA targets in 2026, 2027, or 2028. Management estimates the acquisition will add over $10 million in net revenues during the twelve months following closing through the sale of whole blood, packed red blood cells, serum, and other bio-samples. Closing is anticipated in the third or fourth quarter of 2026, subject to regulatory approvals including FDA licensure. FOXO Technologies Inc. operates subsidiaries providing biospecimen sourcing, hospital services, behavioral health treatment, and biotechnology solutions.